InvestorsHub Logo
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Re: None

Thursday, 07/30/2020 9:24:11 AM

Thursday, July 30, 2020 9:24:11 AM

Post# of 1032
ECOR - “gammaCore is not associated with any drug interactions and can be used several times within a 24-hour period with no multidose-related adverse effects (AEs). In the randomized, double-blind, sham-controlled ACT-1 and ACT-2 trials, gammaCore was superior to sham in rapidly aborting acute pain associated with episodic cluster headache and was well tolerated. 6 In PREVA, a prospective, multicenter, open-label, randomized controlled trial, gammaCore was also superior in reducing the number of attacks compared with controls in addition to being safe and well tolerated.“

https://scholar.google.com.hk/scholar?as_ylo=2020&q=gammacore&hl=en&as_sdt=0,33#d=gs_qabs&u=%23p%3DheYAMS8DVm4J
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ECOR News